In an effort to reduce debt and strategically allocate capital, German conglomerate Fresenius SE has embarked on a significant move to raise €1.1 billion by selling shares and issuing exchangeable bonds tied to Fresenius Medical Care AG. This initiative highlights the company's strategic flexibility and long-term vision in a shifting market landscape.